Atlas Trials

Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.

Clinical trial NCT06364267 · RECRUITING

Trial details

NCT number
NCT06364267
Sponsor
Andrea DeCensi
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2025-10-01
Primary completion
2027-01-31
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.